A personal injury law firm has filed a lawsuit against Novo Nordisk and Eli Lilly and Co., the manufacturers of Ozempic and Mounjaro, over claims that the diabetes drugs, which are popular for aiding weight loss, can cause gastroparesis, a paralysis of the stomach.